
Keywords: AD; Alzheimer's disease; BA; betulinic acid; Aβ; amyloid beta; STZ; streptozotocin; i.h; intra-hippocampal injection; i.c.v; intracerebroventricular administration; PBS; phosphate buffered saline; DMSO; dimethyl sulfoxide; aCSF; artificial cerebrospinal